Quantifying EBV-specific CD8⁺ T cell immunity in patients with post transplant lymphoproliferative disease (PTLD) and other EBV-driven malignancies
Epstein-Barr virus (EBV) specific T cells control EBV-driven proliferation of infected B cells in vivo. Deficient EBV immunity predisposes to post-transplant lymphoproliferative disease (PTLD) and EBV-positive Hodgkin's disease (HD). Treatment for PTLD is reduction in immunosuppression (RIS) al...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2008
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.504585 |